Back to search
FDAFDA · Food and drugs·Recall number D-0508-2017

Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 5511-113-81

Published March 8, 2017 · Recall initiated: February 15, 2017

Summary

FDA records drug Class III recall D-0508-2017, published March 8, 2017 and initiated February 15, 2017. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 4014 cartons; Lot: Lot # KB60036, Exp 12/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications - low dissolution results at S3 stage.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
U.S. Nationwide
Lot
Lot # KB60036, Exp 12/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 5511-113-81 recalled?

Yes. FDA published recall D-0508-2017 on March 8, 2017. Reported hazard: Failed dissolution specifications - low dissolution results at S3 stage.

What should I do if I have this product?

Voluntary: Firm initiated · Letter